Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/25/2003WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
09/25/2003WO2002031146A3 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
09/25/2003WO2002030448A3 Treatment of demyelinating diseases by administering gpe
09/25/2003WO2002028355A3 Methods and compositions for enhancing angiogenesis
09/25/2003WO2002026982A3 Secreted human proteins
09/25/2003WO2002026949A3 Human proteases and polynucleotides encoding the same
09/25/2003WO2002022803A3 Peptide epitopes recognized by antigen specific cd4+ t lymphocytes
09/25/2003WO2002020754A3 Molecules for diagnostics and therapeutics
09/25/2003WO2002016411A3 Binding polypeptides and methods based thereon
09/25/2003WO2002015922A3 New uses for amino acid anticonvulsants for treatment of pain
09/25/2003WO2002014489A9 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
09/25/2003WO2002014368A3 Proteins and nucleic acids encoding the same
09/25/2003WO2002012469A3 A human adenylate kinase family member and uses therefor
09/25/2003WO2002011674A3 Method and reagent for the inhibition of calcium activated chloride channel-1 (clca-1)
09/25/2003WO2002010378A3 Antisense modulation of ptp1b expression
09/25/2003WO2002010364A3 Methods for enhancing targeted gene alteration using oligonucleotides
09/25/2003WO2002008282A3 Bstp-ras/rerg protein and related reagents and methods of use thereof
09/25/2003WO2001077155A3 Orfx polynucleotides and polypeptides
09/25/2003US20030182681 Introducing into a eukaryotic cell a cytotoxic Pseudomonas protein to cause the cell death; disease resistance plant
09/25/2003US20030181711 Myometrial maxi-K channel beta-1 polypeptides
09/25/2003US20030181710 Death domain-containing receptor polynucleotides, polypeptides, and antibodies
09/25/2003US20030181706 Inflammation-associated polynucleotides
09/25/2003US20030181705 Novel human kinases and polynucleotides encoding the same
09/25/2003US20030181703 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181702 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181701 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181698 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181697 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181696 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181695 Methods of treating vascular inflammatory pathology by multiple administration of chimeric anti-TNF antibodies
09/25/2003US20030181692 207 human secreted proteins
09/25/2003US20030181689 Percarboxylated polysaccharides, and a process for their preparation
09/25/2003US20030181687 Heparanase activity neutralizing anti-heparanase monoclonal antibody
09/25/2003US20030181685 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181684 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181683 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181682 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181681 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181680 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181679 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181678 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181677 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181676 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181675 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181674 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181673 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181672 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181671 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181670 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181669 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181668 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181667 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181666 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181664 For modulating cytokine, interferon, and tumor necrosis factor levels
09/25/2003US20030181662 Human procalcitonin and the preparation and use thereof
09/25/2003US20030181661 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
09/25/2003US20030181660 Low-density lipoproteins (LDL); diabetes; autoimmune disorders
09/25/2003US20030181659 Thrombopoietin receptor modulating peptide
09/25/2003US20030181657 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181656 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181655 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181654 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181653 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181652 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181651 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181649 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181648 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181647 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181646 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181645 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181644 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181643 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181642 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181641 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181640 Identification and isolation of novel DNA and recombinant production of novel polypeptides
09/25/2003US20030181639 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181638 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181637 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181636 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181436 Administering iodiscorbate compound containing strontium, iodine, ascorbic acid, and a diamagnetic ion, either zinc, bismuth, or potassium
09/25/2003US20030181422 Cardioprotective phosphonates and malonates
09/25/2003US20030181418 Pharmaceutical composition
09/25/2003US20030181413 Raf protein kinase therapeutics
09/25/2003US20030181407 Steatosis-modulating factors and uses thereof
09/25/2003US20030181405 Interferon alpha plasmids and delivery systems, and methods of making and using the same
09/25/2003US20030181404 Inhibiting cell growth with a genetic engineered kinase
09/25/2003US20030181403 A gene therapy for cancers, comprising a cancer suppressing gene; genetic engineering, duplicated gene, cloned gene
09/25/2003US20030181392 Uses of collagen IV
09/25/2003US20030181391 Dipeptide apoptosis inhibitors and the use thereof
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181389 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
09/25/2003US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire
09/25/2003US20030181387 Intranasal administration of polypeptides in powdered form
09/25/2003US20030181386 Skin wound healing promoters
09/25/2003US20030181385 The LHRH antagonist comprise a peptide compound, wherein a residue of the peptide compound corresponding to the amino acid at position 6 of natural mammalian LHRH comprises a hydrophilic N- acyl moiety, a dipolar moiety, a sulfonium
09/25/2003US20030181384 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
09/25/2003US20030181383 Methods and compositions for treating or preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Trefoil peptides are administered in effective concentrations either alone or in combination with
1 ... 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 ... 3163